Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Domenick Zammit
Observed name:
Domenick A. Zammit
Institutions:
Montreal Children's Hospital,
McGill University Health Centre,
McGill University
Observed institutions:
Montreal Neurological Institute and Hospital,
Montreal Children's Hospital,
McGill University Health Centre,
Jewish General Hospital,
Lady Davis Institute for Medical Research,
McGill University
show all 6
OpenAlex ID:
A5050744243
Comparison of polarization properties of human adult microglia and blood‐derived macrophages
2012
·
Bryce A. Durafourt
, Craig S. Moore
, et al.
·
Glia
·
478
PDF
eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2012
·
Tommy Alain
, Masahiro Morita
, et al.
·
Cancer Research
·
158
Current Trends in Orthognathic Surgery
2023
·
Domenick Zammit
, Russell E. Ettinger
, et al.
·
Medicina
·
47
PDF
Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells
2016
·
Mamatha Bhat
, Akiko Yanagiya
, et al.
·
Oncotarget
·
27
Supplementary Figure 1 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
Supplementary Figure 3 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
Supplementary Figure Legends 1-4 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
Supplementary Figure 4 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
Supplementary Figure 2 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
Supplementary Figure 4 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
PDF
Supplementary Figure 3 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
PDF
Supplementary Figure Legends 1-4 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
PDF
Supplementary Figure 1 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
PDF
Supplementary Figure 2 from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
PDF
Data from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
Data from eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
2023
·
Tommy Alain
, Masahiro Morita
, et al.
Show more works
View as search
Works count:
16
Citation count:
710
H-index:
4
I10-index:
4
Year
Topic
Type